AAAAAA

   
Results: 1-23 |
Results: 23

Authors: Rosenthal, MA Kavar, B Hill, JS Morgan, DJ Nation, RL Stylli, SS Basser, RL Uren, S Geldard, H Green, MD Kahl, SB Kaye, AH
Citation: Ma. Rosenthal et al., Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin, J CL ONCOL, 19(2), 2001, pp. 519-524

Authors: Green, MD
Citation: Md. Green, George Washington Grayson and the Creek Nation, 1843-1920, GREAT PLAIN, 21(2), 2001, pp. 169-170

Authors: Innocenti, F Iyer, L Ramirez, J Green, MD Ratain, MJ
Citation: F. Innocenti et al., Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7, DRUG META D, 29(5), 2001, pp. 686-692

Authors: Coffman, BL Kearney, WR Green, MD Lowery, RG Tephly, TR
Citation: Bl. Coffman et al., Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy, MOLEC PHARM, 59(6), 2001, pp. 1464-1469

Authors: Sanchez, JL Bendet, I Grogl, M Lima, JBP Pang, LW Guimaraes, R Guedes, RH Milhous, WK Green, MD Todd, GD
Citation: Jl. Sanchez et al., Malaria in Brazilian military personnel deployed to Angola, J TRAVEL M, 7(5), 2000, pp. 275-282

Authors: Davis, ID Maher, DW Cebon, JS Green, MD Fox, RM McKendrick, JJ Rybak, ME Boyd, AW
Citation: Id. Davis et al., A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancer, GROW FACTOR, 17(4), 2000, pp. 287

Authors: Basser, RL Underhill, C Davis, I Green, MD Cebon, J Zalcberg, J MacMillan, J Cohen, B Marty, J Fox, RM Begley, CG
Citation: Rl. Basser et al., Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancer, J CL ONCOL, 18(15), 2000, pp. 2852-2861

Authors: Green, MD Mount, DL Wirtz, RA White, NJ
Citation: Md. Green et al., A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate, J PHARM B, 24(1), 2000, pp. 65-70

Authors: Green, MD Rice, JA
Citation: Md. Green et Ja. Rice, Channel-tolerant FH-MFSK acoustic signaling for undersea communications and networks, IEEE J OCEA, 25(1), 2000, pp. 28-39

Authors: Breyer-Pfaff, U Mey, U Green, MD Tephly, TR
Citation: U. Breyer-pfaff et al., Comparative N-glucuronidation kinetics of ketotifen and amitriptyline by expressed human UDP-glucuronosyltransferases and liver microsomes, DRUG META D, 28(8), 2000, pp. 869-872

Authors: Barbier, O Turgeon, D Girard, C Green, MD Tephly, TR Hum, DW Belanger, A
Citation: O. Barbier et al., 3 '-azido-3 '-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7), DRUG META D, 28(5), 2000, pp. 497-502

Authors: Green, MD
Citation: Md. Green, A. Leo Levin: A fond tribute to the master of the classroom, U PA LAW RE, 148(5), 2000, pp. 1357-1361

Authors: Green, MD Schultz, WB
Citation: Md. Green et Wb. Schultz, Tort law deference to FDA regulation of medical devices, GEORGET LAW, 88(7), 2000, pp. 2119-2145

Authors: Green, MD
Citation: Md. Green, A new order of things: Property, power, and the transformation of the Creek Indians, 1733-1816., AM HIST REV, 105(5), 2000, pp. 1733-1733

Authors: Green, MD Bergqvist, Y Mount, DL Corbett, S D'Souza, MJ
Citation: Md. Green et al., Improved validated assay for the determination of mefloquine and its carboxy metabolite in plasma, serum and whole blood using solid-phase extractionand high-performance liquid chromatography, J CHROMAT B, 727(1-2), 1999, pp. 159-165

Authors: Gall, WE Zawada, G Mojarrabi, B Tephly, TR Green, MD Coffman, BL Mackenzie, PI Radominska-Pandya, A
Citation: We. Gall et al., Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7, J STEROID B, 70(1-3), 1999, pp. 101-108

Authors: Talbot, SM Westerman, DA Grigg, AP Toner, GC Wolf, M Bishop, J McKendrick, J Zalcberg, J Levi, J Fox, RM Green, MD
Citation: Sm. Talbot et al., Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors, ANN ONCOL, 10(8), 1999, pp. 907-914

Authors: Basser, RL Abraham, R To, LB Fox, RM Green, MD
Citation: Rl. Basser et al., Cardiac effects of high-dose epirubicin and cyclophosphamide in women withpoor prognosis breast cancer, ANN ONCOL, 10(1), 1999, pp. 53-58

Authors: Green, MD Michaels, MG
Citation: Md. Green et Mg. Michaels, Tacrolimus: Effects and side effects, PEDIAT INF, 18(4), 1999, pp. 372-373

Authors: Clarke, K Basser, RL Underhill, C Mitchell, P Bartlett, J Cher, L Findlay, M Dalley, D Pell, M Byrne, M Geldard, H Hill, JS Maher, D Fox, RM Green, MD Kaye, AH
Citation: K. Clarke et al., KRN8602 (MX2-hydrochloride): An active new agent for the treatment of recurrent high-grade glioma, J CL ONCOL, 17(8), 1999, pp. 2579-2584

Authors: Basser, RL To, LB Collins, JP Begley, CG Keefe, D Cebon, J Bashford, J Durrant, S Szer, J Kotasek, D Juttner, CA Russell, I Maher, DW Olver, I Sheridan, WP Fox, RM Green, MD
Citation: Rl. Basser et al., Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: Five-year follow-up, J CL ONCOL, 17(1), 1999, pp. 82-92

Authors: Green, MD
Citation: Md. Green, Linking arms together: American Indian treaty visions of law and peace, 1600-1800, J SOUTH HIS, 65(1), 1999, pp. 142-143

Authors: Ooi, BS Tjandra, JJ Green, MD
Citation: Bs. Ooi et al., Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer - An overview, DIS COL REC, 42(3), 1999, pp. 403-418
Risultati: 1-23 |